Literature DB >> 15902260

The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.

Kirsten K Youngren1, Douglas Coveney, Xiaoning Peng, Chitralekha Bhattacharya, Laura S Schmidt, Michael L Nickerson, Bruce T Lamb, Jian Min Deng, Richard R Behringer, Blanche Capel, Edward M Rubin, Joseph H Nadeau, Angabin Matin.   

Abstract

In mice, the Ter mutation causes primordial germ cell (PGC) loss in all genetic backgrounds. Ter is also a potent modifier of spontaneous testicular germ cell tumour (TGCT) susceptibility in the 129 family of inbred strains, and markedly increases TGCT incidence in 129-Ter/Ter males. In 129-Ter/Ter mice, some of the remaining PGCs transform into undifferentiated pluripotent embryonal carcinoma cells, and after birth differentiate into various cells and tissues that compose TGCTs. Here, we report the positional cloning of Ter, revealing a point mutation that introduces a termination codon in the mouse orthologue (Dnd1) of the zebrafish dead end (dnd) gene. PGC deficiency is corrected both with bacterial artificial chromosomes that contain Dnd1 and with a Dnd1-encoding transgene. Dnd1 is expressed in fetal gonads during the critical period when TGCTs originate. DND1 has an RNA recognition motif and is most similar to the apobec complementation factor, a component of the cytidine to uridine RNA-editing complex. These results suggest that Ter may adversely affect essential aspects of RNA biology during PGC development. DND1 is the first protein known to have an RNA recognition motif directly implicated as a heritable cause of spontaneous tumorigenesis. TGCT development in the 129-Ter mouse strain models paediatric TGCT in humans. This work will have important implications for our understanding of the genetic control of TGCT pathogenesis and PGC biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902260      PMCID: PMC1421521          DOI: 10.1038/nature03595

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  28 in total

1.  Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells.

Authors:  J Shao; H Sheng; H Inoue; J D Morrow; R N DuBois
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

2.  A conserved RNA-binding protein controls germline stem cells in Caenorhabditis elegans.

Authors:  Sarah L Crittenden; David S Bernstein; Jennifer L Bachorik; Beth E Thompson; Maria Gallegos; Andrei G Petcherski; Gary Moulder; Robert Barstead; Marvin Wickens; Judith Kimble
Journal:  Nature       Date:  2002-05-22       Impact factor: 49.962

3.  Overexpression of an mRNA-binding protein in human colorectal cancer.

Authors:  J Ross; I Lemm; B Berberet
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

4.  Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.

Authors:  Z Ma; S W Morris; V Valentine; M Li; J A Herbrick; X Cui; D Bouman; Y Li; P K Mehta; D Nizetic; Y Kaneko; G C Chan; L C Chan; J Squire; S W Scherer; J K Hitzler
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

5.  Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome.

Authors:  X W Yang; P Model; N Heintz
Journal:  Nat Biotechnol       Date:  1997-09       Impact factor: 54.908

6.  DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC.

Authors:  H A Drabkin; J D West; M Hotfilder; Y M Heng; P Erickson; R Calvo; J Dalmau; R M Gemmill; F Sablitzky
Journal:  Oncogene       Date:  1999-04-22       Impact factor: 9.867

7.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).

Authors:  Aikaterini Barbouti; Mattias Höglund; Bertil Johansson; Carin Lassen; Per-Gunnar Nilsson; Anne Hagemeijer; Felix Mitelman; Thoas Fioretos
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

9.  Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2.

Authors:  Debnath Mukhopadhyay; Courtney W Houchen; Susan Kennedy; Brian K Dieckgraefe; Shrikant Anant
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

10.  Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins.

Authors:  Frederick L Moore; Jadwiga Jaruzelska; Mark S Fox; Jun Urano; Meri T Firpo; Paul J Turek; David M Dorfman; Renee A Reijo Pera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-02       Impact factor: 11.205

View more
  134 in total

1.  Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Authors:  Han Qin; Kathryn Blaschke; Grace Wei; Yuki Ohi; Laure Blouin; Zhongxia Qi; Jingwei Yu; Ru-Fang Yeh; Matthias Hebrok; Miguel Ramalho-Santos
Journal:  Hum Mol Genet       Date:  2012-01-27       Impact factor: 6.150

2.  Elr-type proteins protect Xenopus Dead end mRNA from miR-18-mediated clearance in the soma.

Authors:  Katja Koebernick; Jana Loeber; Patrick Kobina Arthur; Katsiaryna Tarbashevich; Tomas Pieler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  Zebrafish models of germ cell tumor.

Authors:  Joanie C Neumann; Kate Lillard; Vanessa Damoulis; James F Amatruda
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 4.  Germ Line Versus Soma in the Transition from Egg to Embryo.

Authors:  S Zachary Swartz; Gary M Wessel
Journal:  Curr Top Dev Biol       Date:  2015-08-19       Impact factor: 4.897

Review 5.  Single-nucleotide editing: From principle, optimization to application.

Authors:  Jinling Tang; Trevor Lee; Tao Sun
Journal:  Hum Mutat       Date:  2019-09-15       Impact factor: 4.878

6.  Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk.

Authors:  Karlyne M Reilly
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

Review 7.  The stem cell identity of testicular cancer.

Authors:  Amander T Clark
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

8.  Conserved mechanisms for germ cell-specific localization of nanos3 transcripts in teleost species with aquaculture significance.

Authors:  Adrijana Škugor; Krasimir Slanchev; Jacob Seilø Torgersen; Helge Tveiten; Øivind Andersen
Journal:  Mar Biotechnol (NY)       Date:  2013-10-04       Impact factor: 3.619

9.  The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency.

Authors:  Anthony D Krentz; Mark W Murphy; Shinseog Kim; Matthew S Cook; Blanche Capel; Rui Zhu; Angabin Matin; Aaron L Sarver; Keith L Parker; Michael D Griswold; Leendert H J Looijenga; Vivian J Bardwell; David Zarkower
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

10.  MicroRNA genes are frequently located near mouse cancer susceptibility loci.

Authors:  Cinzia Sevignani; George A Calin; Stephanie C Nnadi; Masayoshi Shimizu; Ramana V Davuluri; Terry Hyslop; Peter Demant; Carlo M Croce; Linda D Siracusa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.